Table 3.

Comparison of breast cancer TVDT with prognostic molecular indicators and molecular subtyping (χ±s, d, n=69).

Item	Cases	TVDT	t value/F value	P value
ER
Positive	41	221±156	8.513	0.031
Negative	28	160±86
PR
Positive	40	231±143	5.351	0.048
Negative	29	165±96
HER2
Positive	14	184±71	−0.628	0.739
Negative	55	195±112
Ki-67
Negative (<14%)	33	224±136	11.317	0.018
Positive (≥14%)	36	145±87
Molecular subtyping
Luminal subtype A	29	257±185	13.751*	0.013
Luminal subtype B	12	211±116a
HER2 overexpression	10	184±71ab
Triple negative	18	127±48abc

^*F value.

^aP<0.01, vs. luminal subtype A;

^bP<0.01, vs. luminal subtype B;

^cP<0.01, vs. HER2 overexpression type.